NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research ChannelBioSpace Collaborative Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 

Wednesday, August 11, 2010
 
Alectos Therapeutics Announces Collaboration With Merck & Co., Inc. (MRK) to Develop Drugs for Alzheimer's Disease; Alectos Therapeutics Could Receive $289 Million    More...

Amgen (AMGN) Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial; Vectibix Fails to Meet Primary Endpoint    More...

Cardiome Pharma Corp. (COM.TO) Says Heart Drug Program Delayed, Shares Fall    More...

Eli Lilly and Company (LLY) Plans More Reductions, to Lay Off 500 More Employees    More...

Cholesterol-Drug Developer Aegerion Pharmaceuticals, Inc. Revives Plan for $86.3M IPO    More...

Dicerna Pharmaceuticals Closes $25 Million Series B Financing    More...

Shire plc Sells ADHD Patch Daytrana to Noven Pharmaceuticals Inc. (NOVN)    More...

Emergent BioSolutions (EBS) and Temasek Life Sciences Ventures Establish Joint Venture EPIC BIO Pte Ltd to Develop Broad Spectrum Pandemic Flu Vaccine and Therapeutic    More...

 
More Breaking News


 
 

 Market Summary

 
Vertex Pharmaceuticals (MA) (VRTX) Hep C Drug Works In Half The Time of Current Therapy    More...

SciClone Pharmaceuticals, Inc. (SCLN) Tumbles on SEC Investigation, U.S. DOJ FCPA Compliance Issues    More...

Genzyme Corporation (GENZ) CEO Has $22M Conflict of Interest in Sanofi-Aventis (France) (SASY.PA) Buyout    More...

Endo Pharmaceuticals (ENDP) to Buy Penwest Pharmaceutical (PPCO) for About $168 Million and Submits NDA For New Formulation of Long-Acting Oxymorphone Designed to be Crush-Resistant    More...

Drugmaker Elan Corporation PLC (ELN) Outlines Plan To Cut Debt, Interest; Puts Sale Of Drug Delivery Unit On Hold    More...

Genzyme Corporation (GENZ) Restates Results, Discards More Drugs    More...

Cancer's 'Addiction' Spurs New Treatment Hopes, Yale University Study    More...

Plant-Based Vaccine Company Medicago USA Inc. (MDG) To Bring 85 Jobs To Durham    More...

TetraLogic Pharmaceuticals Completes $32 Million Series C Financing    More...

Elan Corporation PLC (ELN) And Transition Therapeutics Inc. (TTH.TO) Announce Topline Summary Results Of Phase 2 Study and Plans for Phase 3 for ELND005 (Scyllo-inositol)    More...

 
More News

Join the GenePool

     
 
 
 Advanced Search     

 
ED Supplement Causes 'Worrisome' Heartbeat Changes, Loyola University Study    More...
Colder Weather Boosts Heart Attack Risk, London School of Hygiene and Tropical Medicine Study    More...
Should 'Male Menopause' Be Treated? - University of Washington Study    More...
'Tiger Balm' Gives FDA Officials Headaches    More...
Vitamin B3 as a Novel Approach to Treat Fungal Infections, University Of Montreal Study    More...
Free Clinical Info App For IPhone And IPod Touch Helps Doctors And Nurses Record, Grade Side Effects In Clinical Trials Reveals Children's Hospital of Philadelphia    More...
No Significant Esophageal Cancer Risk From Osteoporosis Drug: Queen’s University Study    More...
Snail Venom Inspires Powerful Pain Reliever, University of Queensland Study    More...
 
More Featured News




 
Vertex Pharmaceuticals is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is focused on viral diseases, inflammation, autoimmune diseases, cancer, pain and bacterial infection. Vertex co-discovered the HIV protease inhibitor, Lexiva, with GlaxoSmithKline.

NEW! View Vertex's latest job posting: Director, Alliance Management


Show me jobs for this employer
 
Feature Employer
 
Do You Really Know How People Perceive You?    More...

10 Things Recruiters Won't Tell You (But I Will!)    More...

Tips for Video, Phone Interviews; They Require Just as Much Prep    More...

What Aspects of Your Juggle Should You Put on a Resume?    More...

Informational Interview is Catching On    More...

The No. 1 Quality For Career Success    More...

Successful Job Search Strategies for Mature Workers    More...

Avoid These Mistakes and Impress Hiring Manager    More...

5 Reasons You Didn't Get The Job    More...

5 Unconventional Ways to Find a Job    More...

 
More Career Tips